John L. Jefferies, MD, FACC

John L. Jefferies, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Protalix(MODEST), Abbott Laboratories(SIGNIFICANT), Sanofi Genzyme(SIGNIFICANT), Amicus(MODEST), Medtronic(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Chiesi(MODEST), Stealth Biotherapeutics(SIGNIFICANT), Novartis(NONE), Nuwellis(SIGNIFICANT), Alnylam(MODEST), Bristol Myers Squibb(MODEST), Daxor(SIGNIFICANT) SPEAKER'S BUREAU: Sanofi Genzyme(SIGNIFICANT), Pfizer Inc(MODEST), Ambry Genetics(MODEST), NS Pharma(MODEST) RESEARCH/RESEARCH GRANTS: Pfizer(SIGNIFICANT), Myokardia(SIGNIFICANT), Biocardia(SIGNIFICANT), Veru(SIGNIFICANT), HeartBeam(SIGNIFICANT), Innolife(SIGNIFICANT), V Wave(SIGNIFICANT)

View Full Disclosure